Paolo Gallo

9PUBLICATIONS
73CO-AUTHORS
Gene mappingPharmacogenomicsHaematological tumoursMajor global burdens of diseaseToxicology (incl. clinical toxicology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 26, 2026
Hepatic Alpha-1 Antitrypsin Globules in Compound Heterozygous SERPINA1 Variants Previously Considered Non-Polymerizing: A Case Report.

|Nov 27, 2025
Epidemiologic Characteristics Determining the Choice of Direct-Acting Antiviral Therapy in HCV Patients: An Italian Real-World Evidence Study.

Nicola Pugliese, Fabio Conti, Valerio Rosato

|Jun 13, 2025
Lenvatinib Is Highly Effective in Patients with Hepatocellular Carcinoma Related to Both Metabolic Dysfunction-Associated Steatohepatitis and Alcoholic Etiology: A Propensity Score Analysis.

Rodolfo Sacco, Edoardo G Giannini, Raffaella Tortora

|Feb 26, 2025
Assessment of Response and Safety of Bulevirtide Treatment in Patients with Chronic Delta Virus Infection: The ARISTOTLE Pilot Observational Study.

Luca Rinaldi, Mauro Viganò, Alessia Ciancio

|Oct 16, 2024
Safety of Sofosbuvir-Based Direct-Acting Antivirals for Hepatitis C Virus Infection and Direct Oral Anticoagulant Co-Administration.

Valerio Rosato, Riccardo Nevola, Marcello Dallio

|Jul 13, 2024
Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study.

Paolo Gallo, Antonio De Vincentis, Francesca Terracciani

Pageof 2

Frequent Collaborators

4 joint publications

Valerio Rosato

3 joint publications

Rodolfo Sacco

3 joint publications

Andrea Falcomatà

2 joint publications

Panaiotis Finamore